Published by Frank Prenesti on 16th September 2022
(Sharecast News) - AstraZeneca and Sanofi said their Beyfortus drug for the prevention of lower respiratory tract disease in newborns and infants has been recommended for marketing authorisation in the European Union
URL: http://www.digitallook.com/dl/news/story/32967940/...